×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MLYS – mineralys therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MLYS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/2
08:11 am
mlys
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) had its price target raised by analysts at HC Wainwright from $30.00 to $42.00. They now have a "buy" rating on the stock.
Low
Report
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) had its price target raised by analysts at HC Wainwright from $30.00 to $42.00. They now have a "buy" rating on the stock.
3/29
02:46 pm
mlys
New blood pressure drug helps people with uncontrolled hypertension in trial [CNBC]
Medium
Report
New blood pressure drug helps people with uncontrolled hypertension in trial [CNBC]
3/29
02:30 pm
mlys
Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiology’s Annual Scientific Session & Expo (ACC.25)
Medium
Report
Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiology’s Annual Scientific Session & Expo (ACC.25)
3/25
08:00 am
mlys
Mineralys Therapeutics to Host KOL Call to Discuss Clinical Data from Launch-HTN and Advance-HTN Pivotal Trials Tuesday, April 1, 2025, at 8:00 AM ET
Low
Report
Mineralys Therapeutics to Host KOL Call to Discuss Clinical Data from Launch-HTN and Advance-HTN Pivotal Trials Tuesday, April 1, 2025, at 8:00 AM ET
3/18
04:01 pm
mlys
Mineralys Therapeutics Announces Closing of Underwriters’ Option to Purchase Additional Shares in Connection with Public Offering of Common Stock
Medium
Report
Mineralys Therapeutics Announces Closing of Underwriters’ Option to Purchase Additional Shares in Connection with Public Offering of Common Stock
3/17
08:07 am
mlys
Mineralys Therapeutics Announces Data from the Phase 2 Advance-HTN Trial of Lorundrosat for the Treatment of Hypertension Has Been Accepted as a Late-Breaking Presentation at the 2025 American College of Cardiology's Annual Scientific Session & Expo [Yah
Low
Report
Mineralys Therapeutics Announces Data from the Phase 2 Advance-HTN Trial of Lorundrosat for the Treatment of Hypertension Has Been Accepted as a Late-Breaking Presentation at the 2025 American College of Cardiology's Annual Scientific Session & Expo [Yah
3/17
08:00 am
mlys
Mineralys Therapeutics Announces Data from the Phase 2 Advance-HTN Trial of Lorundrosat for the Treatment of Hypertension Has Been Accepted as a Late-Breaking Presentation at the 2025 American College of Cardiology’s Annual Scientific Session & Expo
Low
Report
Mineralys Therapeutics Announces Data from the Phase 2 Advance-HTN Trial of Lorundrosat for the Treatment of Hypertension Has Been Accepted as a Late-Breaking Presentation at the 2025 American College of Cardiology’s Annual Scientific Session & Expo
3/11
10:20 pm
mlys
Mineralys Therapeutics Announces Pricing of $175.0 Million Underwritten Public Offering of Common Stock
Medium
Report
Mineralys Therapeutics Announces Pricing of $175.0 Million Underwritten Public Offering of Common Stock
Date
Time
Symbol
Company Name
Action
%Chg
2/12/2025
07:00 am
mlys
mineralys therapeutics, inc.
BEAT
Report
8.4%
mineralys therapeutics, inc.
2/12/2025
07:00 am
mlys
mineralys therapeutics, inc.
BEAT
Report
3.2%
mineralys therapeutics, inc.
2/12/2025
07:00 am
mlys
mineralys therapeutics, inc.
BEAT
Report
2.7%
mineralys therapeutics, inc.
2/12/2025
07:00 am
mlys
mineralys therapeutics, inc.
BEAT
Report
2.7%
mineralys therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/15
08:39 pm
mlys
Form 4 Mineralys Therapeutics, For: Apr 14 Filed by: Rodman David Malcom
Medium
Report
Form 4 Mineralys Therapeutics, For: Apr 14 Filed by: Rodman David Malcom
4/15
08:36 pm
mlys
Form 4 Mineralys Therapeutics, For: Apr 11 Filed by: Levy Adam Scott
Medium
Report
Form 4 Mineralys Therapeutics, For: Apr 11 Filed by: Levy Adam Scott
4/15
08:34 pm
mlys
Form 4 Mineralys Therapeutics, For: Apr 11 Filed by: Congleton Jon
Medium
Report
Form 4 Mineralys Therapeutics, For: Apr 11 Filed by: Congleton Jon
4/14
04:11 pm
mlys
Form 144 Mineralys Therapeutics, Filed by: Rodman David Malcom
Low
Report
Form 144 Mineralys Therapeutics, Filed by: Rodman David Malcom
4/11
05:49 pm
mlys
Form 144 Mineralys Therapeutics, Filed by: Congleton Jon
Medium
Report
Form 144 Mineralys Therapeutics, Filed by: Congleton Jon
4/11
05:49 pm
mlys
Form 144 Mineralys Therapeutics, Filed by: Levy Adam Scott
Medium
Report
Form 144 Mineralys Therapeutics, Filed by: Levy Adam Scott
4/9
08:22 am
mlys
Form ARS Mineralys Therapeutics, For: Dec 31
High
Report
Form ARS Mineralys Therapeutics, For: Dec 31
4/9
08:18 am
mlys
Form DEFA14A Mineralys Therapeutics,
High
Report
Form DEFA14A Mineralys Therapeutics,
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: